Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Neurosurgery | 18 | 2024 | 670 | 3.520 |
Why?
|
Brain Neoplasms | 43 | 2024 | 8981 | 2.540 |
Why?
|
Craniotomy | 11 | 2023 | 741 | 1.430 |
Why?
|
Glioblastoma | 20 | 2024 | 3480 | 1.310 |
Why?
|
Neurosurgical Procedures | 22 | 2024 | 2055 | 1.080 |
Why?
|
Internship and Residency | 7 | 2024 | 5865 | 1.070 |
Why?
|
Glioma | 11 | 2023 | 3418 | 0.880 |
Why?
|
Central Nervous System Neoplasms | 4 | 2024 | 916 | 0.770 |
Why?
|
Spinal Cord Neoplasms | 3 | 2019 | 263 | 0.740 |
Why?
|
Intracranial Aneurysm | 10 | 2012 | 1276 | 0.710 |
Why?
|
Tremor | 1 | 2020 | 190 | 0.670 |
Why?
|
School Admission Criteria | 1 | 2020 | 105 | 0.670 |
Why?
|
Evoked Potentials, Somatosensory | 1 | 2021 | 246 | 0.670 |
Why?
|
Telemetry | 1 | 2020 | 199 | 0.670 |
Why?
|
Defensive Medicine | 3 | 2015 | 47 | 0.650 |
Why?
|
Hydrocephalus | 7 | 2022 | 764 | 0.650 |
Why?
|
Astrocytoma | 3 | 2018 | 775 | 0.530 |
Why?
|
Hematoma, Subdural | 2 | 2014 | 127 | 0.530 |
Why?
|
Isocitrate Dehydrogenase | 6 | 2024 | 929 | 0.520 |
Why?
|
Antineoplastic Agents, Alkylating | 2 | 2016 | 617 | 0.500 |
Why?
|
Dura Mater | 2 | 2015 | 290 | 0.500 |
Why?
|
Thalamus | 1 | 2021 | 1040 | 0.480 |
Why?
|
Guidelines as Topic | 1 | 2020 | 1386 | 0.460 |
Why?
|
Intracranial Hemorrhages | 4 | 2014 | 820 | 0.460 |
Why?
|
Hematoma, Subdural, Acute | 1 | 2013 | 16 | 0.450 |
Why?
|
Motor Cortex | 1 | 2021 | 997 | 0.440 |
Why?
|
Insurance, Health, Reimbursement | 1 | 2016 | 385 | 0.430 |
Why?
|
Valproic Acid | 1 | 2016 | 442 | 0.430 |
Why?
|
Interviews as Topic | 1 | 2020 | 2676 | 0.430 |
Why?
|
Dacarbazine | 1 | 2016 | 559 | 0.420 |
Why?
|
Conflict of Interest | 3 | 2012 | 548 | 0.420 |
Why?
|
Practice Guidelines as Topic | 6 | 2021 | 7378 | 0.410 |
Why?
|
Frontal Sinus | 1 | 2012 | 51 | 0.400 |
Why?
|
Cerebellar Neoplasms | 2 | 2014 | 587 | 0.400 |
Why?
|
Drug Monitoring | 1 | 2018 | 960 | 0.400 |
Why?
|
Vascular Neoplasms | 1 | 2013 | 167 | 0.400 |
Why?
|
Tachycardia, Ventricular | 1 | 2020 | 1297 | 0.390 |
Why?
|
Insurance, Liability | 1 | 2012 | 101 | 0.390 |
Why?
|
Humans | 154 | 2024 | 758406 | 0.380 |
Why?
|
Spina Bifida Occulta | 1 | 2011 | 31 | 0.380 |
Why?
|
Hospitals, Special | 1 | 2011 | 91 | 0.370 |
Why?
|
Patents as Topic | 1 | 2012 | 111 | 0.370 |
Why?
|
Skull Fractures | 1 | 2012 | 202 | 0.360 |
Why?
|
Meningeal Carcinomatosis | 2 | 2021 | 63 | 0.360 |
Why?
|
Fistula | 1 | 2012 | 214 | 0.360 |
Why?
|
Hyperplasia | 1 | 2013 | 1154 | 0.360 |
Why?
|
Cervical Vertebrae | 5 | 2016 | 977 | 0.340 |
Why?
|
Sinus Thrombosis, Intracranial | 1 | 2011 | 110 | 0.340 |
Why?
|
Subarachnoid Hemorrhage, Traumatic | 1 | 2009 | 13 | 0.330 |
Why?
|
Malpractice | 3 | 2015 | 555 | 0.330 |
Why?
|
Salivary Gland Neoplasms | 1 | 2013 | 304 | 0.330 |
Why?
|
Decompressive Craniectomy | 4 | 2015 | 76 | 0.330 |
Why?
|
Neoplasm Recurrence, Local | 3 | 2016 | 9273 | 0.320 |
Why?
|
Spondylitis, Ankylosing | 1 | 2010 | 152 | 0.320 |
Why?
|
Ownership | 1 | 2011 | 339 | 0.310 |
Why?
|
Postoperative Complications | 7 | 2020 | 15637 | 0.310 |
Why?
|
Electrocardiography | 2 | 2020 | 6363 | 0.300 |
Why?
|
Choroid Plexus | 2 | 2007 | 237 | 0.290 |
Why?
|
Telomerase | 4 | 2024 | 745 | 0.290 |
Why?
|
Genetic Linkage | 3 | 2007 | 2381 | 0.280 |
Why?
|
Vasospasm, Intracranial | 1 | 2009 | 215 | 0.270 |
Why?
|
Health Care Surveys | 2 | 2022 | 2432 | 0.270 |
Why?
|
Parkinson Disease | 1 | 2020 | 2862 | 0.270 |
Why?
|
Disease Management | 6 | 2021 | 2500 | 0.270 |
Why?
|
Evidence-Based Practice | 2 | 2020 | 494 | 0.260 |
Why?
|
Central Nervous System Vascular Malformations | 3 | 2011 | 140 | 0.250 |
Why?
|
Male | 72 | 2024 | 358747 | 0.250 |
Why?
|
Female | 78 | 2024 | 390323 | 0.250 |
Why?
|
Airway Obstruction | 1 | 2010 | 661 | 0.250 |
Why?
|
Oligodendroglioma | 2 | 2016 | 279 | 0.240 |
Why?
|
Lymphoma | 2 | 2024 | 1896 | 0.240 |
Why?
|
Radiosurgery | 4 | 2020 | 1342 | 0.240 |
Why?
|
Adult | 58 | 2024 | 219935 | 0.230 |
Why?
|
Brain Injuries | 6 | 2015 | 2044 | 0.230 |
Why?
|
Registries | 2 | 2019 | 8175 | 0.220 |
Why?
|
Microelectrodes | 2 | 2021 | 304 | 0.220 |
Why?
|
Physicians | 2 | 2012 | 4580 | 0.220 |
Why?
|
Spinal Fractures | 1 | 2010 | 702 | 0.220 |
Why?
|
Ventriculostomy | 2 | 2015 | 131 | 0.210 |
Why?
|
Bioethics | 1 | 2024 | 117 | 0.210 |
Why?
|
Brain Edema | 3 | 2013 | 603 | 0.210 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3076 | 0.210 |
Why?
|
Databases, Factual | 3 | 2021 | 7980 | 0.210 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3196 | 0.210 |
Why?
|
Middle Aged | 46 | 2024 | 219568 | 0.200 |
Why?
|
Chromosomes, Human, Pair 1 | 1 | 2004 | 635 | 0.200 |
Why?
|
Attitude of Health Personnel | 2 | 2015 | 3867 | 0.200 |
Why?
|
Cysts | 1 | 2007 | 681 | 0.200 |
Why?
|
Indocyanine Green | 1 | 2023 | 236 | 0.200 |
Why?
|
Spine | 4 | 2012 | 1111 | 0.190 |
Why?
|
Fourth Ventricle | 2 | 2012 | 32 | 0.190 |
Why?
|
Gliosarcoma | 1 | 2021 | 113 | 0.190 |
Why?
|
Meningomyelocele | 1 | 2022 | 170 | 0.180 |
Why?
|
Air Ambulances | 2 | 2012 | 92 | 0.180 |
Why?
|
Pandemics | 1 | 2020 | 8611 | 0.180 |
Why?
|
Telecommunications | 1 | 2020 | 80 | 0.180 |
Why?
|
Vertebral Artery | 2 | 2011 | 185 | 0.180 |
Why?
|
Aneurysm, Ruptured | 1 | 2005 | 459 | 0.180 |
Why?
|
United States | 13 | 2024 | 72136 | 0.170 |
Why?
|
Single-Cell Analysis | 5 | 2019 | 2379 | 0.170 |
Why?
|
Eccrine Glands | 1 | 2020 | 52 | 0.170 |
Why?
|
Mutation | 11 | 2024 | 29915 | 0.170 |
Why?
|
Congresses as Topic | 3 | 2019 | 799 | 0.170 |
Why?
|
Brain Mapping | 5 | 2023 | 6570 | 0.170 |
Why?
|
Neurotoxicity Syndromes | 1 | 2023 | 300 | 0.170 |
Why?
|
Spinal Neoplasms | 2 | 2020 | 716 | 0.170 |
Why?
|
Meningeal Neoplasms | 2 | 2021 | 1247 | 0.170 |
Why?
|
Cerebral Ventricles | 2 | 2015 | 542 | 0.170 |
Why?
|
Aged | 34 | 2024 | 168218 | 0.170 |
Why?
|
Neoplastic Stem Cells | 3 | 2017 | 1346 | 0.160 |
Why?
|
Cerebral Ventricle Neoplasms | 2 | 2011 | 44 | 0.160 |
Why?
|
Evidence-Based Medicine | 4 | 2021 | 3671 | 0.160 |
Why?
|
Skull Neoplasms | 1 | 2020 | 173 | 0.160 |
Why?
|
Intraoperative Complications | 2 | 2019 | 1184 | 0.160 |
Why?
|
Treatment Outcome | 20 | 2020 | 64378 | 0.160 |
Why?
|
Catheterization | 2 | 2016 | 1426 | 0.160 |
Why?
|
Microsurgery | 4 | 2011 | 796 | 0.150 |
Why?
|
Sweat Gland Neoplasms | 1 | 2020 | 117 | 0.150 |
Why?
|
False Positive Reactions | 1 | 2020 | 956 | 0.150 |
Why?
|
Retrospective Studies | 22 | 2024 | 80168 | 0.150 |
Why?
|
Curriculum | 2 | 2023 | 3717 | 0.150 |
Why?
|
Video Recording | 1 | 2023 | 954 | 0.150 |
Why?
|
Stroke | 6 | 2015 | 9694 | 0.150 |
Why?
|
Intracranial Arteriovenous Malformations | 2 | 2011 | 366 | 0.140 |
Why?
|
Drug Therapy | 1 | 2020 | 503 | 0.140 |
Why?
|
Propofol | 1 | 2023 | 606 | 0.140 |
Why?
|
Bone Marrow | 2 | 2018 | 2909 | 0.140 |
Why?
|
Education, Distance | 1 | 2020 | 259 | 0.140 |
Why?
|
Craniocerebral Trauma | 2 | 2011 | 491 | 0.140 |
Why?
|
Drugs, Investigational | 1 | 2019 | 212 | 0.140 |
Why?
|
Cross-Sectional Studies | 4 | 2024 | 25956 | 0.140 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 5 | 2021 | 11709 | 0.140 |
Why?
|
Antibodies, Bispecific | 1 | 2019 | 191 | 0.140 |
Why?
|
Warfarin | 2 | 2016 | 1482 | 0.140 |
Why?
|
Cranial Irradiation | 1 | 2019 | 390 | 0.130 |
Why?
|
Neuroendoscopes | 1 | 2015 | 7 | 0.130 |
Why?
|
Chondroma | 1 | 2015 | 53 | 0.130 |
Why?
|
Lumbar Vertebrae | 4 | 2016 | 1868 | 0.130 |
Why?
|
Combined Modality Therapy | 3 | 2019 | 8530 | 0.130 |
Why?
|
Acrocephalosyndactylia | 1 | 2016 | 91 | 0.130 |
Why?
|
Plasma | 2 | 2016 | 584 | 0.130 |
Why?
|
Blood Component Transfusion | 1 | 2016 | 141 | 0.120 |
Why?
|
Critical Pathways | 1 | 2019 | 473 | 0.120 |
Why?
|
Optic Nerve Neoplasms | 1 | 2015 | 45 | 0.120 |
Why?
|
Young Adult | 16 | 2024 | 58808 | 0.120 |
Why?
|
Magnetic Resonance Imaging, Interventional | 1 | 2016 | 187 | 0.120 |
Why?
|
Hemangioblastoma | 1 | 2014 | 63 | 0.120 |
Why?
|
Temporal Lobe | 3 | 2018 | 1688 | 0.120 |
Why?
|
Aged, 80 and over | 11 | 2024 | 58683 | 0.120 |
Why?
|
Osteophyte | 1 | 2014 | 44 | 0.120 |
Why?
|
Sequence Analysis, RNA | 3 | 2017 | 2001 | 0.120 |
Why?
|
Glutarates | 1 | 2016 | 244 | 0.120 |
Why?
|
Neuroendoscopy | 1 | 2015 | 98 | 0.110 |
Why?
|
Seizures | 3 | 2019 | 2919 | 0.110 |
Why?
|
Multicenter Studies as Topic | 3 | 2024 | 1705 | 0.110 |
Why?
|
Leukocytosis | 1 | 2015 | 251 | 0.110 |
Why?
|
Lymphoma, Non-Hodgkin | 1 | 2021 | 1373 | 0.110 |
Why?
|
Temporal Bone | 2 | 2016 | 683 | 0.110 |
Why?
|
Antidotes | 1 | 2014 | 137 | 0.110 |
Why?
|
Scalp | 2 | 2020 | 389 | 0.110 |
Why?
|
Feasibility Studies | 2 | 2021 | 5199 | 0.110 |
Why?
|
Diagnosis, Differential | 3 | 2020 | 12951 | 0.110 |
Why?
|
Magnetic Resonance Imaging | 18 | 2024 | 36284 | 0.110 |
Why?
|
Speech | 1 | 2018 | 550 | 0.110 |
Why?
|
Spinal Cord Compression | 2 | 2014 | 234 | 0.110 |
Why?
|
Hypernatremia | 1 | 2013 | 78 | 0.110 |
Why?
|
Saline Solution, Hypertonic | 1 | 2013 | 114 | 0.110 |
Why?
|
Von Hippel-Lindau Tumor Suppressor Protein | 1 | 2014 | 305 | 0.110 |
Why?
|
Brain Concussion | 2 | 2021 | 1397 | 0.110 |
Why?
|
Arnold-Chiari Malformation | 2 | 2011 | 158 | 0.110 |
Why?
|
Craniopharyngioma | 1 | 2015 | 277 | 0.110 |
Why?
|
beta-Alanine | 1 | 2013 | 81 | 0.100 |
Why?
|
Spinal Cord | 2 | 2011 | 1814 | 0.100 |
Why?
|
Developing Countries | 2 | 2024 | 2866 | 0.100 |
Why?
|
Quality of Life | 2 | 2024 | 13285 | 0.100 |
Why?
|
Demyelinating Diseases | 1 | 2015 | 351 | 0.100 |
Why?
|
Microfluidics | 1 | 2018 | 652 | 0.100 |
Why?
|
Guanine Nucleotides | 1 | 2012 | 55 | 0.100 |
Why?
|
Peripheral Nervous System Neoplasms | 1 | 2013 | 133 | 0.100 |
Why?
|
Fever | 2 | 2021 | 1617 | 0.100 |
Why?
|
Skull Fracture, Basilar | 1 | 2011 | 6 | 0.100 |
Why?
|
Acute Lung Injury | 1 | 2016 | 367 | 0.100 |
Why?
|
Ambulances | 1 | 2012 | 91 | 0.100 |
Why?
|
Protein Kinase Inhibitors | 3 | 2024 | 5629 | 0.100 |
Why?
|
Blood Coagulation Factors | 1 | 2014 | 365 | 0.100 |
Why?
|
Neurocytoma | 1 | 2011 | 29 | 0.100 |
Why?
|
Brain | 9 | 2023 | 26947 | 0.100 |
Why?
|
Spinal Fusion | 2 | 2011 | 1280 | 0.100 |
Why?
|
Sodium-Potassium-Chloride Symporters | 2 | 2009 | 104 | 0.100 |
Why?
|
Internet | 2 | 2016 | 3082 | 0.100 |
Why?
|
MELAS Syndrome | 1 | 2012 | 56 | 0.100 |
Why?
|
Cochlear Implantation | 1 | 2016 | 315 | 0.100 |
Why?
|
Hospital-Physician Relations | 1 | 2011 | 17 | 0.100 |
Why?
|
Petrous Bone | 1 | 2011 | 84 | 0.100 |
Why?
|
Abducens Nerve Diseases | 1 | 2012 | 44 | 0.100 |
Why?
|
Neoplastic Cells, Circulating | 2 | 2017 | 938 | 0.100 |
Why?
|
Hernia | 1 | 2011 | 68 | 0.100 |
Why?
|
Rhombencephalon | 1 | 2011 | 81 | 0.100 |
Why?
|
Ion Transport | 2 | 2009 | 318 | 0.090 |
Why?
|
Antigens, Neoplasm | 1 | 2019 | 1997 | 0.090 |
Why?
|
Cerebrospinal Fluid Rhinorrhea | 1 | 2011 | 87 | 0.090 |
Why?
|
Cerebral Cortex | 3 | 2021 | 5759 | 0.090 |
Why?
|
Tumor Microenvironment | 3 | 2022 | 3840 | 0.090 |
Why?
|
Intracranial Arterial Diseases | 1 | 2011 | 22 | 0.090 |
Why?
|
Education, Medical, Graduate | 1 | 2023 | 2359 | 0.090 |
Why?
|
Chondroblastoma | 1 | 2011 | 48 | 0.090 |
Why?
|
Hemifacial Spasm | 1 | 2011 | 24 | 0.090 |
Why?
|
Syringomyelia | 1 | 2011 | 67 | 0.090 |
Why?
|
Ethics, Research | 1 | 2012 | 176 | 0.090 |
Why?
|
Survival Rate | 4 | 2024 | 12721 | 0.090 |
Why?
|
Athletic Injuries | 1 | 2021 | 1211 | 0.090 |
Why?
|
Head Injuries, Closed | 1 | 2012 | 133 | 0.090 |
Why?
|
Neuroectodermal Tumors, Primitive | 1 | 2011 | 136 | 0.090 |
Why?
|
Bone Cysts, Aneurysmal | 1 | 2011 | 70 | 0.090 |
Why?
|
Blood Gas Analysis | 1 | 2011 | 377 | 0.090 |
Why?
|
Polyradiculopathy | 1 | 2010 | 23 | 0.090 |
Why?
|
Angiogenesis Inhibitors | 1 | 2020 | 2047 | 0.090 |
Why?
|
Transportation of Patients | 1 | 2011 | 174 | 0.090 |
Why?
|
Globus Pallidus | 1 | 2012 | 250 | 0.090 |
Why?
|
Ventriculoperitoneal Shunt | 1 | 2012 | 186 | 0.090 |
Why?
|
Income | 1 | 2019 | 1872 | 0.090 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2015 | 611 | 0.090 |
Why?
|
Stents | 2 | 2013 | 3162 | 0.090 |
Why?
|
Bone Nails | 1 | 2011 | 218 | 0.090 |
Why?
|
Antithrombins | 1 | 2013 | 294 | 0.090 |
Why?
|
Leukemia, Biphenotypic, Acute | 1 | 2010 | 32 | 0.090 |
Why?
|
Electric Stimulation | 3 | 2021 | 1732 | 0.090 |
Why?
|
Proto-Oncogene Proteins B-raf | 2 | 2021 | 2053 | 0.090 |
Why?
|
Spinal Diseases | 2 | 2014 | 559 | 0.090 |
Why?
|
Hematoma, Epidural, Spinal | 1 | 2010 | 37 | 0.090 |
Why?
|
Search Engine | 1 | 2011 | 140 | 0.090 |
Why?
|
Prednisolone | 1 | 2011 | 326 | 0.090 |
Why?
|
Blast Crisis | 1 | 2010 | 101 | 0.090 |
Why?
|
Pituitary Diseases | 1 | 2011 | 135 | 0.090 |
Why?
|
Incidence | 3 | 2019 | 21272 | 0.090 |
Why?
|
Blood Coagulation | 1 | 2016 | 1149 | 0.080 |
Why?
|
Polyvinyls | 1 | 2010 | 154 | 0.080 |
Why?
|
Neurocysticercosis | 1 | 2011 | 91 | 0.080 |
Why?
|
Foreign-Body Migration | 1 | 2011 | 218 | 0.080 |
Why?
|
Brain Diseases | 1 | 2019 | 1541 | 0.080 |
Why?
|
Tomography, X-Ray Computed | 11 | 2019 | 20500 | 0.080 |
Why?
|
Cri-du-Chat Syndrome | 1 | 2009 | 13 | 0.080 |
Why?
|
Laser Therapy | 1 | 2016 | 1089 | 0.080 |
Why?
|
Dimethyl Sulfoxide | 1 | 2010 | 251 | 0.080 |
Why?
|
Surgical Instruments | 1 | 2012 | 385 | 0.080 |
Why?
|
Spondylolisthesis | 1 | 2011 | 173 | 0.080 |
Why?
|
Orthotic Devices | 1 | 2010 | 129 | 0.080 |
Why?
|
Research Report | 1 | 2012 | 367 | 0.080 |
Why?
|
Aneurysm, False | 1 | 2011 | 254 | 0.080 |
Why?
|
Neoplasm Proteins | 1 | 2021 | 3609 | 0.080 |
Why?
|
Bone Neoplasms | 2 | 2012 | 2531 | 0.080 |
Why?
|
Epilepsy | 2 | 2021 | 3269 | 0.080 |
Why?
|
Neuroma, Acoustic | 1 | 2013 | 459 | 0.080 |
Why?
|
Electroencephalography | 2 | 2021 | 6187 | 0.080 |
Why?
|
Gene Expression Regulation, Neoplastic | 3 | 2021 | 8506 | 0.080 |
Why?
|
Skull Base | 1 | 2011 | 291 | 0.080 |
Why?
|
Chordoma | 1 | 2012 | 346 | 0.080 |
Why?
|
Language | 1 | 2018 | 1532 | 0.080 |
Why?
|
Surgical Wound Infection | 2 | 2015 | 1526 | 0.080 |
Why?
|
Infant | 8 | 2022 | 36055 | 0.080 |
Why?
|
Frontal Lobe | 1 | 2015 | 1419 | 0.080 |
Why?
|
Breast Neoplasms | 4 | 2023 | 21017 | 0.080 |
Why?
|
Facial Nerve | 1 | 2011 | 277 | 0.080 |
Why?
|
Thrombectomy | 1 | 2013 | 690 | 0.080 |
Why?
|
Carcinoma | 1 | 2020 | 2330 | 0.080 |
Why?
|
Brain Stem Neoplasms | 1 | 2010 | 190 | 0.080 |
Why?
|
Sacrum | 1 | 2010 | 277 | 0.080 |
Why?
|
Vascular System Injuries | 1 | 2011 | 246 | 0.080 |
Why?
|
Cerebral Revascularization | 1 | 2011 | 250 | 0.080 |
Why?
|
Hyponatremia | 1 | 2011 | 279 | 0.080 |
Why?
|
Imaging, Three-Dimensional | 3 | 2016 | 4048 | 0.070 |
Why?
|
Connective Tissue Diseases | 1 | 2011 | 285 | 0.070 |
Why?
|
T-Lymphocytes | 3 | 2023 | 10171 | 0.070 |
Why?
|
Nausea | 2 | 2021 | 677 | 0.070 |
Why?
|
Benzimidazoles | 1 | 2013 | 855 | 0.070 |
Why?
|
Famous Persons | 1 | 2009 | 109 | 0.070 |
Why?
|
Cerebral Aqueduct | 1 | 2007 | 40 | 0.070 |
Why?
|
Follow-Up Studies | 5 | 2024 | 39059 | 0.070 |
Why?
|
Lod Score | 2 | 2006 | 602 | 0.070 |
Why?
|
Influenza A Virus, H1N1 Subtype | 1 | 2011 | 447 | 0.070 |
Why?
|
Dystonic Disorders | 1 | 2012 | 342 | 0.070 |
Why?
|
Hospitals | 4 | 2019 | 3887 | 0.070 |
Why?
|
Magnetic Resonance Angiography | 2 | 2011 | 1431 | 0.070 |
Why?
|
Students, Medical | 1 | 2020 | 1927 | 0.070 |
Why?
|
Clinical Competence | 1 | 2023 | 4775 | 0.070 |
Why?
|
Peripheral Nerves | 1 | 2011 | 475 | 0.070 |
Why?
|
Aneurysm | 1 | 2010 | 336 | 0.070 |
Why?
|
Pituitary Neoplasms | 1 | 2015 | 1313 | 0.070 |
Why?
|
Steroids | 1 | 2012 | 926 | 0.070 |
Why?
|
Prospective Studies | 8 | 2024 | 54137 | 0.070 |
Why?
|
Cohort Studies | 8 | 2021 | 41256 | 0.070 |
Why?
|
Hemorrhage | 2 | 2016 | 3400 | 0.070 |
Why?
|
Cerebral Infarction | 1 | 2011 | 981 | 0.070 |
Why?
|
Prognosis | 5 | 2024 | 29557 | 0.070 |
Why?
|
Hypertension | 2 | 2011 | 8499 | 0.070 |
Why?
|
Genetic Predisposition to Disease | 2 | 2007 | 17768 | 0.070 |
Why?
|
Family Health | 1 | 2011 | 1257 | 0.070 |
Why?
|
Lateral Ventricles | 1 | 2007 | 146 | 0.070 |
Why?
|
Rare Diseases | 1 | 2012 | 619 | 0.070 |
Why?
|
Bone Transplantation | 1 | 2011 | 922 | 0.070 |
Why?
|
Neoplasm Metastasis | 2 | 2020 | 4901 | 0.070 |
Why?
|
Meningioma | 1 | 2015 | 1217 | 0.070 |
Why?
|
Quality Assurance, Health Care | 1 | 2016 | 2167 | 0.070 |
Why?
|
Postoperative Care | 1 | 2012 | 1471 | 0.070 |
Why?
|
Anticonvulsants | 1 | 2016 | 1881 | 0.070 |
Why?
|
Nervous System Diseases | 2 | 2024 | 1647 | 0.070 |
Why?
|
Critical Care | 2 | 2023 | 2692 | 0.070 |
Why?
|
Cell Line, Tumor | 5 | 2023 | 16886 | 0.060 |
Why?
|
Chlorides | 1 | 2008 | 663 | 0.060 |
Why?
|
Drug Therapy, Combination | 1 | 2016 | 6293 | 0.060 |
Why?
|
Decompression, Surgical | 1 | 2011 | 604 | 0.060 |
Why?
|
Head and Neck Neoplasms | 1 | 2020 | 2882 | 0.060 |
Why?
|
Cocaine-Related Disorders | 1 | 2009 | 461 | 0.060 |
Why?
|
Disclosure | 1 | 2011 | 738 | 0.060 |
Why?
|
Chromosomes, Human, Pair 14 | 1 | 2006 | 286 | 0.060 |
Why?
|
Endoscopy | 1 | 2015 | 1834 | 0.060 |
Why?
|
Intensive Care Units | 2 | 2023 | 3732 | 0.060 |
Why?
|
Melanoma | 2 | 2022 | 5691 | 0.060 |
Why?
|
Monitoring, Intraoperative | 1 | 2011 | 939 | 0.060 |
Why?
|
Brain Stem | 1 | 2010 | 857 | 0.060 |
Why?
|
Promoter Regions, Genetic | 3 | 2024 | 5779 | 0.060 |
Why?
|
Third Ventricle | 1 | 2005 | 74 | 0.060 |
Why?
|
Chromosomes, Human, Pair 11 | 1 | 2006 | 410 | 0.060 |
Why?
|
Cooperative Behavior | 1 | 2012 | 1501 | 0.060 |
Why?
|
Immunotherapy | 1 | 2020 | 4641 | 0.060 |
Why?
|
Multivariate Analysis | 4 | 2016 | 12096 | 0.060 |
Why?
|
Patient Transfer | 1 | 2011 | 777 | 0.060 |
Why?
|
Cerebrospinal Fluid Shunts | 1 | 2005 | 195 | 0.060 |
Why?
|
Antineoplastic Agents | 2 | 2021 | 13591 | 0.060 |
Why?
|
Molecular Targeted Therapy | 1 | 2015 | 2796 | 0.060 |
Why?
|
Embolization, Therapeutic | 2 | 2010 | 1407 | 0.060 |
Why?
|
Emergency Medical Services | 2 | 2012 | 1915 | 0.060 |
Why?
|
Social Class | 1 | 2012 | 1999 | 0.060 |
Why?
|
Heparin | 1 | 2011 | 1632 | 0.050 |
Why?
|
Disease Progression | 2 | 2018 | 13468 | 0.050 |
Why?
|
Mentors | 1 | 2009 | 660 | 0.050 |
Why?
|
Deep Brain Stimulation | 1 | 2012 | 825 | 0.050 |
Why?
|
International Normalized Ratio | 2 | 2016 | 382 | 0.050 |
Why?
|
Ovarian Neoplasms | 1 | 2020 | 4876 | 0.050 |
Why?
|
Bioethical Issues | 1 | 2024 | 121 | 0.050 |
Why?
|
Medicaid | 1 | 2016 | 2807 | 0.050 |
Why?
|
Spinal Dysraphism | 1 | 2005 | 174 | 0.050 |
Why?
|
Anticoagulants | 2 | 2016 | 4777 | 0.050 |
Why?
|
Data Collection | 1 | 2012 | 3322 | 0.050 |
Why?
|
Penetrance | 1 | 2004 | 388 | 0.050 |
Why?
|
Vascular Surgical Procedures | 1 | 2011 | 1470 | 0.050 |
Why?
|
Immunotherapy, Adoptive | 2 | 2023 | 1454 | 0.050 |
Why?
|
Adolescent | 9 | 2019 | 87892 | 0.050 |
Why?
|
Estrogen Receptor beta | 1 | 2023 | 168 | 0.050 |
Why?
|
Accidental Falls | 1 | 2010 | 1056 | 0.050 |
Why?
|
Molecular Biology | 1 | 2006 | 580 | 0.050 |
Why?
|
Child | 8 | 2022 | 79818 | 0.050 |
Why?
|
Neurons | 1 | 2021 | 9416 | 0.050 |
Why?
|
Zambia | 1 | 2022 | 257 | 0.050 |
Why?
|
History, 19th Century | 3 | 2011 | 720 | 0.050 |
Why?
|
Tumor Suppressor Protein p53 | 2 | 2023 | 2912 | 0.050 |
Why?
|
Wavelet Analysis | 1 | 2021 | 55 | 0.050 |
Why?
|
Polymorphism, Single Nucleotide | 2 | 2015 | 15773 | 0.050 |
Why?
|
Anti-Inflammatory Agents | 1 | 2011 | 1793 | 0.050 |
Why?
|
Fibrinolytic Agents | 1 | 2011 | 2071 | 0.050 |
Why?
|
Fluorescence | 1 | 2023 | 749 | 0.050 |
Why?
|
Anorexia | 1 | 2021 | 154 | 0.050 |
Why?
|
Mice, Inbred ICR | 1 | 2021 | 364 | 0.050 |
Why?
|
Corpus Callosum | 1 | 2005 | 749 | 0.050 |
Why?
|
Pedigree | 2 | 2006 | 4578 | 0.040 |
Why?
|
Logistic Models | 3 | 2016 | 13276 | 0.040 |
Why?
|
Periodicals as Topic | 1 | 2011 | 1462 | 0.040 |
Why?
|
Neurofibromin 1 | 1 | 2021 | 190 | 0.040 |
Why?
|
Influenza, Human | 1 | 2011 | 1516 | 0.040 |
Why?
|
Insurance Coverage | 1 | 2011 | 1933 | 0.040 |
Why?
|
Biopsy | 2 | 2024 | 6768 | 0.040 |
Why?
|
Brain Ischemia | 2 | 2013 | 3047 | 0.040 |
Why?
|
Muscle, Skeletal | 2 | 2012 | 4902 | 0.040 |
Why?
|
Child, Preschool | 6 | 2015 | 42062 | 0.040 |
Why?
|
Hepatitis | 1 | 2021 | 229 | 0.040 |
Why?
|
Wounds and Injuries | 1 | 2012 | 2476 | 0.040 |
Why?
|
Carcinoma, Ductal | 1 | 2020 | 97 | 0.040 |
Why?
|
Extracellular Space | 1 | 2021 | 564 | 0.040 |
Why?
|
Electrophysiological Phenomena | 1 | 2021 | 308 | 0.040 |
Why?
|
Risk | 3 | 2016 | 9599 | 0.040 |
Why?
|
Cell Lineage | 2 | 2019 | 2533 | 0.040 |
Why?
|
Diagnostic Imaging | 1 | 2013 | 3526 | 0.040 |
Why?
|
RNA, Messenger | 1 | 2014 | 12759 | 0.040 |
Why?
|
Cerebral Hemorrhage | 1 | 2010 | 2650 | 0.040 |
Why?
|
DNA, Neoplasm | 1 | 2024 | 1745 | 0.040 |
Why?
|
Social Environment | 1 | 2004 | 1023 | 0.040 |
Why?
|
Genetic Variation | 1 | 2014 | 6548 | 0.040 |
Why?
|
Estrogen Receptor alpha | 1 | 2023 | 580 | 0.040 |
Why?
|
Polymerase Chain Reaction | 2 | 2020 | 6068 | 0.040 |
Why?
|
Risk Factors | 6 | 2019 | 73809 | 0.040 |
Why?
|
Abdominal Wall | 1 | 2020 | 165 | 0.040 |
Why?
|
Diffusion Tensor Imaging | 2 | 2023 | 2386 | 0.040 |
Why?
|
Medicare | 1 | 2016 | 6741 | 0.040 |
Why?
|
Tamoxifen | 1 | 2023 | 963 | 0.040 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2021 | 698 | 0.040 |
Why?
|
Age Factors | 2 | 2005 | 18358 | 0.040 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2014 | 10146 | 0.040 |
Why?
|
Carcinoma, Renal Cell | 1 | 2013 | 3217 | 0.040 |
Why?
|
Contrast Media | 1 | 2011 | 5298 | 0.040 |
Why?
|
Informed Consent | 1 | 2024 | 1003 | 0.040 |
Why?
|
Gene Expression Profiling | 3 | 2021 | 9404 | 0.040 |
Why?
|
Time Factors | 6 | 2016 | 39872 | 0.040 |
Why?
|
Somatosensory Cortex | 1 | 2021 | 511 | 0.040 |
Why?
|
Health Resources | 1 | 2023 | 931 | 0.040 |
Why?
|
Mice, Inbred C57BL | 3 | 2021 | 22003 | 0.040 |
Why?
|
Radiography | 3 | 2014 | 6954 | 0.040 |
Why?
|
Receptor, Notch1 | 1 | 2020 | 495 | 0.040 |
Why?
|
Phonetics | 1 | 2018 | 198 | 0.040 |
Why?
|
Cerebrovascular Circulation | 3 | 2012 | 2731 | 0.030 |
Why?
|
Lymphoid Tissue | 1 | 2018 | 445 | 0.030 |
Why?
|
Vomiting | 1 | 2020 | 651 | 0.030 |
Why?
|
Acoustic Stimulation | 1 | 2021 | 1232 | 0.030 |
Why?
|
Exanthema | 1 | 2021 | 504 | 0.030 |
Why?
|
Acute Disease | 1 | 2007 | 7225 | 0.030 |
Why?
|
Kidney Neoplasms | 1 | 2013 | 4312 | 0.030 |
Why?
|
Physics | 1 | 2016 | 90 | 0.030 |
Why?
|
Central Nervous System | 1 | 2023 | 1333 | 0.030 |
Why?
|
Chromosome Mapping | 1 | 2004 | 4624 | 0.030 |
Why?
|
Sphingosine | 1 | 2018 | 308 | 0.030 |
Why?
|
Lymphopenia | 1 | 2018 | 280 | 0.030 |
Why?
|
Internationality | 1 | 2022 | 1000 | 0.030 |
Why?
|
History, 20th Century | 3 | 2011 | 2772 | 0.030 |
Why?
|
Lysophospholipids | 1 | 2018 | 338 | 0.030 |
Why?
|
Tectum Mesencephali | 1 | 2015 | 18 | 0.030 |
Why?
|
Genetic Heterogeneity | 1 | 2019 | 723 | 0.030 |
Why?
|
Lung Neoplasms | 1 | 2020 | 13245 | 0.030 |
Why?
|
PTEN Phosphohydrolase | 1 | 2021 | 1113 | 0.030 |
Why?
|
Fluorescent Dyes | 1 | 2023 | 1897 | 0.030 |
Why?
|
Propionibacterium acnes | 1 | 2015 | 65 | 0.030 |
Why?
|
Animals | 10 | 2021 | 167768 | 0.030 |
Why?
|
Research Design | 1 | 2011 | 6157 | 0.030 |
Why?
|
Hypnotics and Sedatives | 1 | 2023 | 1176 | 0.030 |
Why?
|
Audiometry | 1 | 2016 | 253 | 0.030 |
Why?
|
Cell Differentiation | 3 | 2019 | 11471 | 0.030 |
Why?
|
Predictive Value of Tests | 2 | 2015 | 15225 | 0.030 |
Why?
|
Mice, Inbred NOD | 1 | 2019 | 1825 | 0.030 |
Why?
|
Sports | 1 | 2021 | 699 | 0.030 |
Why?
|
Socioeconomic Factors | 2 | 2023 | 7818 | 0.030 |
Why?
|
Macaca mulatta | 1 | 2021 | 2316 | 0.030 |
Why?
|
Frozen Sections | 1 | 2015 | 153 | 0.030 |
Why?
|
Hospital Mortality | 3 | 2014 | 5272 | 0.030 |
Why?
|
Patient Admission | 2 | 2012 | 1372 | 0.030 |
Why?
|
Neoplasms | 1 | 2023 | 22032 | 0.030 |
Why?
|
Intraoperative Period | 1 | 2015 | 512 | 0.030 |
Why?
|
Tissue Fixation | 1 | 2015 | 241 | 0.030 |
Why?
|
Fatigue | 1 | 2021 | 1542 | 0.030 |
Why?
|
Wakefulness | 1 | 2021 | 1256 | 0.030 |
Why?
|
Semantics | 1 | 2018 | 599 | 0.030 |
Why?
|
False Negative Reactions | 1 | 2015 | 573 | 0.030 |
Why?
|
Oximes | 1 | 2015 | 303 | 0.030 |
Why?
|
Neoplasms, Experimental | 1 | 2019 | 1228 | 0.030 |
Why?
|
Endocytosis | 1 | 2018 | 958 | 0.030 |
Why?
|
Valine | 1 | 2015 | 408 | 0.030 |
Why?
|
Principal Component Analysis | 1 | 2017 | 940 | 0.030 |
Why?
|
Antibodies, Monoclonal | 1 | 2011 | 9160 | 0.030 |
Why?
|
Chromosomes, Human, Pair 3 | 1 | 2014 | 315 | 0.030 |
Why?
|
Athletes | 1 | 2021 | 1125 | 0.030 |
Why?
|
Co-Repressor Proteins | 1 | 2014 | 191 | 0.030 |
Why?
|
Biological Transport | 1 | 2018 | 2084 | 0.030 |
Why?
|
Spinal Nerve Roots | 1 | 2013 | 121 | 0.030 |
Why?
|
Regulatory Elements, Transcriptional | 1 | 2014 | 183 | 0.030 |
Why?
|
Pyrimidinones | 1 | 2015 | 383 | 0.030 |
Why?
|
Hyperthermia, Induced | 1 | 2016 | 416 | 0.030 |
Why?
|
Colitis | 1 | 2021 | 1229 | 0.030 |
Why?
|
Coronary Artery Disease | 1 | 2012 | 6362 | 0.030 |
Why?
|
Nicardipine | 1 | 2012 | 60 | 0.030 |
Why?
|
Exosomes | 1 | 2017 | 423 | 0.030 |
Why?
|
Comprehension | 1 | 2018 | 619 | 0.030 |
Why?
|
Hematologic Neoplasms | 1 | 2024 | 1890 | 0.030 |
Why?
|
Gram-Positive Bacterial Infections | 1 | 2015 | 343 | 0.030 |
Why?
|
Compassionate Use Trials | 1 | 2012 | 50 | 0.030 |
Why?
|
Cross-Cultural Comparison | 1 | 2015 | 635 | 0.030 |
Why?
|
Spleen | 1 | 2018 | 2296 | 0.030 |
Why?
|
Glasgow Outcome Scale | 1 | 2012 | 104 | 0.020 |
Why?
|
DNA Mutational Analysis | 1 | 2020 | 4106 | 0.020 |
Why?
|
Emergency Service, Hospital | 3 | 2019 | 7810 | 0.020 |
Why?
|
Lumbosacral Region | 1 | 2013 | 291 | 0.020 |
Why?
|
C-Reactive Protein | 1 | 2023 | 3812 | 0.020 |
Why?
|
Neuronal Plasticity | 1 | 2000 | 1429 | 0.020 |
Why?
|
Ear, Inner | 1 | 2016 | 424 | 0.020 |
Why?
|
Deafness | 1 | 2016 | 457 | 0.020 |
Why?
|
Consensus | 1 | 2021 | 3099 | 0.020 |
Why?
|
Neoplasm Invasiveness | 1 | 2020 | 3617 | 0.020 |
Why?
|
Mice | 4 | 2021 | 81101 | 0.020 |
Why?
|
Anterior Cerebral Artery | 1 | 2011 | 50 | 0.020 |
Why?
|
Receptors, Platelet-Derived Growth Factor | 1 | 2012 | 178 | 0.020 |
Why?
|
Hyperglycemia | 1 | 2020 | 1368 | 0.020 |
Why?
|
Cochlear Implants | 1 | 2016 | 338 | 0.020 |
Why?
|
Point Mutation | 1 | 2016 | 1593 | 0.020 |
Why?
|
Intracranial Pressure | 1 | 2013 | 325 | 0.020 |
Why?
|
Legislation, Medical | 1 | 2011 | 98 | 0.020 |
Why?
|
History, Medieval | 1 | 2011 | 62 | 0.020 |
Why?
|
History, 16th Century | 1 | 2011 | 70 | 0.020 |
Why?
|
Circle of Willis | 1 | 2011 | 79 | 0.020 |
Why?
|
History, 17th Century | 1 | 2011 | 107 | 0.020 |
Why?
|
Neuroglia | 1 | 2016 | 944 | 0.020 |
Why?
|
Internal Fixators | 1 | 2011 | 183 | 0.020 |
Why?
|
Inappropriate ADH Syndrome | 1 | 2011 | 60 | 0.020 |
Why?
|
Prevalence | 3 | 2012 | 15651 | 0.020 |
Why?
|
History, Ancient | 1 | 2011 | 211 | 0.020 |
Why?
|
Neoplasm, Residual | 1 | 2015 | 1007 | 0.020 |
Why?
|
Laminectomy | 1 | 2011 | 224 | 0.020 |
Why?
|
Texas | 1 | 2011 | 402 | 0.020 |
Why?
|
Trauma Severity Indices | 1 | 2012 | 478 | 0.020 |
Why?
|
Vascular Malformations | 1 | 2016 | 464 | 0.020 |
Why?
|
Dominance, Cerebral | 1 | 2012 | 622 | 0.020 |
Why?
|
Clinical Trials, Phase I as Topic | 1 | 2012 | 326 | 0.020 |
Why?
|
Pyridones | 1 | 2015 | 784 | 0.020 |
Why?
|
Middle Cerebral Artery | 1 | 2011 | 275 | 0.020 |
Why?
|
Canada | 1 | 2015 | 2111 | 0.020 |
Why?
|
Bicycling | 1 | 2011 | 176 | 0.020 |
Why?
|
Glutamic Acid | 1 | 2015 | 1167 | 0.020 |
Why?
|
Hip Joint | 1 | 2016 | 1006 | 0.020 |
Why?
|
Hypertrophy | 1 | 2011 | 555 | 0.020 |
Why?
|
Disease-Free Survival | 1 | 2020 | 6821 | 0.020 |
Why?
|
Diskectomy | 1 | 2011 | 209 | 0.020 |
Why?
|
Thoracic Vertebrae | 1 | 2014 | 596 | 0.020 |
Why?
|
Glasgow Coma Scale | 1 | 2011 | 579 | 0.020 |
Why?
|
Imidazoles | 1 | 2015 | 1179 | 0.020 |
Why?
|
Epithelial-Mesenchymal Transition | 1 | 2014 | 730 | 0.020 |
Why?
|
Iliac Artery | 1 | 2011 | 342 | 0.020 |
Why?
|
Heart Block | 1 | 2011 | 392 | 0.020 |
Why?
|
Radiculopathy | 1 | 2011 | 200 | 0.020 |
Why?
|
Calcium Channel Blockers | 1 | 2012 | 694 | 0.020 |
Why?
|
Blood Cell Count | 1 | 2010 | 395 | 0.020 |
Why?
|
Neural Stem Cells | 1 | 2016 | 882 | 0.020 |
Why?
|
Losartan | 1 | 2011 | 265 | 0.020 |
Why?
|
Phylogeny | 1 | 2016 | 2774 | 0.020 |
Why?
|
Geography | 1 | 2011 | 660 | 0.020 |
Why?
|
Surgery, Computer-Assisted | 1 | 2016 | 1008 | 0.020 |
Why?
|
Survival Analysis | 1 | 2021 | 10112 | 0.020 |
Why?
|
Neurologic Examination | 1 | 2012 | 914 | 0.020 |
Why?
|
Gene Silencing | 1 | 2014 | 1507 | 0.020 |
Why?
|
Microglia | 1 | 2017 | 1349 | 0.020 |
Why?
|
Syncope | 1 | 2011 | 427 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2020 | 10748 | 0.020 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 1 | 2014 | 1136 | 0.020 |
Why?
|
Knee Joint | 1 | 2016 | 1663 | 0.020 |
Why?
|
DNA Copy Number Variations | 1 | 2016 | 2012 | 0.020 |
Why?
|
RNA | 1 | 2018 | 2716 | 0.020 |
Why?
|
Movement Disorders | 1 | 2011 | 459 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 2015 | 4839 | 0.020 |
Why?
|
Cell Membrane Permeability | 1 | 2009 | 575 | 0.020 |
Why?
|
Decision Making | 1 | 2021 | 3915 | 0.020 |
Why?
|
Genotype | 2 | 2016 | 12945 | 0.020 |
Why?
|
DNA, Mitochondrial | 1 | 2012 | 856 | 0.020 |
Why?
|
Endothelium | 1 | 2009 | 764 | 0.020 |
Why?
|
Cell Death | 1 | 2012 | 1668 | 0.020 |
Why?
|
Orthopedic Procedures | 1 | 2016 | 1263 | 0.020 |
Why?
|
Subarachnoid Hemorrhage | 1 | 2014 | 1031 | 0.020 |
Why?
|
Surgical Flaps | 1 | 2015 | 1669 | 0.020 |
Why?
|
Observer Variation | 1 | 2012 | 2600 | 0.020 |
Why?
|
In Situ Hybridization | 1 | 2010 | 1900 | 0.020 |
Why?
|
Leukocyte Count | 1 | 2010 | 1593 | 0.020 |
Why?
|
Cerebral Ventriculography | 1 | 2005 | 44 | 0.020 |
Why?
|
Employment | 1 | 2012 | 1112 | 0.020 |
Why?
|
Accidents, Traffic | 1 | 2011 | 814 | 0.020 |
Why?
|
Tissue Plasminogen Activator | 1 | 2011 | 1156 | 0.020 |
Why?
|
Trauma Centers | 1 | 2011 | 933 | 0.020 |
Why?
|
Drainage | 1 | 2011 | 1161 | 0.020 |
Why?
|
Arteries | 1 | 2011 | 1125 | 0.020 |
Why?
|
Symporters | 1 | 2008 | 360 | 0.020 |
Why?
|
Angiography | 1 | 2011 | 1599 | 0.020 |
Why?
|
Angioplasty, Balloon, Coronary | 1 | 2012 | 1730 | 0.020 |
Why?
|
Parietal Lobe | 1 | 2010 | 849 | 0.020 |
Why?
|
Sensitivity and Specificity | 1 | 2020 | 14641 | 0.020 |
Why?
|
Pacemaker, Artificial | 1 | 2011 | 808 | 0.020 |
Why?
|
History, 18th Century | 1 | 2005 | 207 | 0.010 |
Why?
|
Patient-Centered Care | 1 | 2015 | 1415 | 0.010 |
Why?
|
Regression Analysis | 1 | 2014 | 6354 | 0.010 |
Why?
|
Syndrome | 1 | 2011 | 3262 | 0.010 |
Why?
|
Benzamides | 1 | 2010 | 1368 | 0.010 |
Why?
|
Vision Disorders | 1 | 2011 | 1084 | 0.010 |
Why?
|
Sequence Analysis, DNA | 1 | 2014 | 4711 | 0.010 |
Why?
|
Odds Ratio | 1 | 2016 | 9650 | 0.010 |
Why?
|
Cerebellum | 1 | 2011 | 1497 | 0.010 |
Why?
|
Coronary Artery Bypass | 1 | 2012 | 2189 | 0.010 |
Why?
|
Aorta | 1 | 2011 | 2037 | 0.010 |
Why?
|
Boston | 1 | 2016 | 9304 | 0.010 |
Why?
|
Blood-Brain Barrier | 1 | 2009 | 1018 | 0.010 |
Why?
|
Length of Stay | 1 | 2016 | 6439 | 0.010 |
Why?
|
Linear Models | 1 | 2012 | 5862 | 0.010 |
Why?
|
Motor Activity | 2 | 2004 | 2685 | 0.010 |
Why?
|
Reoperation | 1 | 2012 | 4282 | 0.010 |
Why?
|
Macrophages | 1 | 2017 | 5737 | 0.010 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2012 | 3759 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2015 | 11070 | 0.010 |
Why?
|
Gene Expression | 1 | 2014 | 7583 | 0.010 |
Why?
|
Electronic Health Records | 1 | 2019 | 4761 | 0.010 |
Why?
|
Rats, Sprague-Dawley | 2 | 2004 | 8143 | 0.010 |
Why?
|
Antihypertensive Agents | 1 | 2011 | 2016 | 0.010 |
Why?
|
Nerve Tissue Proteins | 1 | 2014 | 4406 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2016 | 10416 | 0.010 |
Why?
|
Epigenesis, Genetic | 1 | 2014 | 3754 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2019 | 18119 | 0.010 |
Why?
|
Flow Cytometry | 1 | 2010 | 5864 | 0.010 |
Why?
|
Piperazines | 1 | 2010 | 2511 | 0.010 |
Why?
|
Coronary Vessels | 1 | 2011 | 3072 | 0.010 |
Why?
|
Aspirin | 1 | 2011 | 3131 | 0.010 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2011 | 2747 | 0.010 |
Why?
|
Maze Learning | 1 | 2000 | 477 | 0.010 |
Why?
|
Massachusetts | 1 | 2011 | 8823 | 0.010 |
Why?
|
Patient Discharge | 1 | 2011 | 3433 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2014 | 18940 | 0.010 |
Why?
|
Pyrimidines | 1 | 2010 | 3006 | 0.010 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2006 | 3774 | 0.010 |
Why?
|
Thrombosis | 1 | 2011 | 2929 | 0.010 |
Why?
|
Delivery of Health Care | 1 | 2015 | 5331 | 0.010 |
Why?
|
Comorbidity | 1 | 2011 | 10495 | 0.010 |
Why?
|
Rats | 2 | 2004 | 23679 | 0.010 |
Why?
|
Behavior, Animal | 1 | 2004 | 1866 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2012 | 14490 | 0.010 |
Why?
|
Positron-Emission Tomography | 1 | 2012 | 6457 | 0.010 |
Why?
|
Smoking | 1 | 2011 | 9051 | 0.010 |
Why?
|
Transcription Factors | 1 | 2014 | 12094 | 0.010 |
Why?
|
Risk Assessment | 1 | 2016 | 23884 | 0.010 |
Why?
|
Environment | 1 | 2000 | 1118 | 0.010 |
Why?
|
Recovery of Function | 1 | 2004 | 2970 | 0.010 |
Why?
|
Hospitalization | 1 | 2011 | 10652 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2011 | 26183 | 0.010 |
Why?
|
Pregnancy | 1 | 2012 | 29742 | 0.010 |
Why?
|
Phenotype | 1 | 2006 | 16534 | 0.000 |
Why?
|
Cognition | 1 | 2000 | 6953 | 0.000 |
Why?
|